2005
Community Incidence of Hepatitis B and C among Reincarcerated Women
Macalino G, Vlahov D, Dickinson B, Schwartzapfel B, Rich J. Community Incidence of Hepatitis B and C among Reincarcerated Women. Clinical Infectious Diseases 2005, 41: 998-1002. PMID: 16142665, DOI: 10.1086/432936.Peer-Reviewed Original ResearchConceptsHepatitis B virusIncidence of HBVHCV infectionHepatitis BHepatitis C virus infectionC virus infectionDrug treatment servicesDrug-dependent personsIncident infectionsHIV testingBaseline prevalenceB virusCommunity incidenceIncidence rateVirus infectionTreatment servicesDrug useDrug dependenceInfectious diseasesInfectionSerum samplesIncidenceStudy periodWomenHCV
2001
Collaboration among Community Members, Local Health Service Providers, and Researchers in an Urban Research Center in Harlem, New York
Galea S, Factor S, Bonner S, Foley M, Freudenberg N, Latka M, Palermo A, Vlahov D. Collaboration among Community Members, Local Health Service Providers, and Researchers in an Urban Research Center in Harlem, New York. Public Health Reports 2001, 116: 530-539. PMID: 12196612, PMCID: PMC1497380, DOI: 10.1093/phr/116.6.530.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAsthmaChildCommunity Health PlanningCommunity ParticipationCommunity-Institutional RelationsCooperative BehaviorDecision Making, OrganizationalHealth Planning CouncilsHealth PrioritiesHealth Services AccessibilityHealth Services ResearchHepatitis CHIV InfectionsHumansModels, OrganizationalNew York CityPublic Health AdministrationSocial EnvironmentSubstance Abuse, IntravenousUrban HealthConceptsInjection drug usersCommunity advisory boardUrban Research CenterDrug usersInfectious diseasesLocal health service providersPublic health professionalsSelf-management skillsHealth service providersUrban Epidemiologic StudiesCenter experienceAsthma awarenessEpidemiologic studiesCare providersLocal community-based organizationsHealth professionalsProblem substance useAsthmaChild care providersSubstance useEducational interventionSubstance usersCommunity healthCommunity-based organizationsInterventionMultiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France
Moatti J, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple Access to Sterile Syringes for Injection Drug Users: Vending Machines, Needle Exchange Programs and Legal Pharmacy Sales in Marseille, France. European Addiction Research 2001, 7: 40-45. PMID: 11316925, DOI: 10.1159/000050713.Peer-Reviewed Original ResearchConceptsInjection drug usersNeedle exchange programsSterile syringesNEP usersNew syringesPharmacy salesCharacteristics of IDUsDrug usersPrevention of HIVDrug use characteristicsHIV prevention programsSelf-administered questionnaireMethadone programsHeroin injectorsUseful adjunctPrevention programsInfectious diseasesProgram utilizationHIVSyringesPharmacyExchange programsQuestionnaireBuprenorphineDisease
1999
Direct Comparison of Time to AIDS and Infectious Disease Death Between HIV Seroconverter Injection Drug Users in Italy and the United States: Results From the ALIVE and ISS Studies
Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles C, Astemborski J. Direct Comparison of Time to AIDS and Infectious Disease Death Between HIV Seroconverter Injection Drug Users in Italy and the United States: Results From the ALIVE and ISS Studies. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 275-282. PMID: 10077177, DOI: 10.1097/00042560-199903010-00010.Peer-Reviewed Original ResearchConceptsInjection drug usersDate of seroconversionYear of seroconversionMedian timeRelative hazardGroups of IDUsDrug usersInfectious diseasesCohort of IDUsFirst positive HIV testClinic-based cohortSimilar median timeHIV disease progressionProspective cohort studyPositive HIV testInjection drug useCommunity-based cohortHIV-positive individualsInfectious disease deathsTime of seroconversionDrug use characteristicsTerms of ageProportion of womenALIVE studyCohort study
1998
Prognostic Indicators for AIDS and Infectious Disease Death in HIV-Infected Injection Drug Users: Plasma Viral Load and CD4+ Cell Count
Vlahov D, Graham N, Hoover D, Flynn C, Bartlett J, Margolick J, Lyles C, Nelson K, Smith D, Holmberg S, Farzadegan H. Prognostic Indicators for AIDS and Infectious Disease Death in HIV-Infected Injection Drug Users: Plasma Viral Load and CD4+ Cell Count. JAMA 1998, 279: 35-40. PMID: 9424041, DOI: 10.1001/jama.279.1.35.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAIDS-Related Opportunistic InfectionsBiomarkersBlack or African AmericanCD4 Lymphocyte CountDisease ProgressionFemaleHIV-1HumansMalePrognosisProportional Hazards ModelsProspective StudiesRegression AnalysisRNA, ViralSubstance Abuse, IntravenousSurvival AnalysisViral LoadConceptsInfectious disease deathsInjection drug usersPlasma viral loadViral loadDisease deathsCell countDrug usersPrognostic indicatorHuman immunodeficiency virus type 1 (HIV-1) viral loadAfrican American injection drug usersPlasma HIV-1 RNAHIV-1 viral loadInfectious diseasesClinical AIDS diagnosisLevels of CD4Kaplan-Meier analysisHIV-1 RNAPrognosis of personsPowerful prognostic informationProportional hazards modelCases of AIDSGood predictive valueCell count measurementsMedian followCohort study
1995
Geographic Variation in HIV Infection among Injecting Drug Users within Barcelona
Roca J, Vlahov D, Borrell C, Jansa J, Brugal T, Yazbeck H, Muñoz A. Geographic Variation in HIV Infection among Injecting Drug Users within Barcelona. Substance Use & Misuse 1995, 30: 219-229. PMID: 7759174, DOI: 10.3109/10826089509060744.Peer-Reviewed Original Research